Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Many people report improvements in energy levels, mental clarity, and cognitive function after treatment
The critical design decisions included: GIP backbone selection : Starting from GIP rather than GLP-1, as GIP naturally has weak cross-reactivity with GLP-1R, providing a scaffold for optimization Aib2 substitution : Replacing Ala2 with alpha-aminoisobutyric acid for DPP-4 resistance (identical strategy to semaglutide) C-terminal extension : Adding a GGPSSGAPPPS (Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser) 11-residue C-terminal extension that enhances GLP-1R binding C-20 fatty diacid acylation : Attaching an eicosanedioic acid (C-20 diacid) at Lys20 via a Glu-2xOEG linker for albumin binding The resulting molecule exhibits approximately 5:1 selectivity for GIPR over GLP-1R it is a full GIPR agonist and a partial GLP-1R agonist, yet clinically achieves superior outcomes to selective full GLP-1R agonists [7]
The weight you lose on tirzepatide comes from sustained caloric deficit driven by reduced appetite and slower gastric emptying
As DCFH-DA is a general ROS probe, the use of more specific probes or NOX-inhibitors in the future would help to further understand the response of Bd infection on host redox status
US$ 27.07
US$ 22.85
US$ 28.19
US$ 24.36
US$ 25.07
US$ 26.11
US$ 21.86
US$ 26.42
